IGUHEAL-25 Tablets – Iguratimod 25 mg

IGUHEAL-25 Tablets by Farlex Pharmaceuticals contain Iguratimod 25 mg, an immunomodulatory and anti-inflammatory pharmaceutical molecule used in the management of certain autoimmune and inflammatory conditions under medical supervision.

Iguratimod is a disease-modifying antirheumatic drug (DMARD) with immunomodulatory properties. IGUHEAL-25 is developed for professional pharmaceutical requirements and can be considered by pharma distributors, PCD pharma franchise partners, pharma marketers, stockists, institutional buyers and healthcare business partners looking to expand their pharmaceutical product portfolio.

Key Product Information

Brand Name: IGUHEAL-25
Generic: Iguratimod
Strength: 25 mg
Dosage Form: Film-Coated Tablets
Pack: 10 × 10 Tablets
Manufacturer/Marketer: Farlex Pharmaceuticals
Category: Immunomodulatory / Anti-inflammatory
Prescription: As directed by the physician

Uses of Iguratimod 25 mg

Iguratimod is used under medical supervision in the management of selected rheumatoid arthritis and other autoimmune or inflammatory conditions. Its immunomodulatory activity may help regulate abnormal immune responses and inflammatory processes.

The medicine should be used strictly according to the prescribing physician's recommendation.

Why Add IGUHEAL-25 to Your Pharma Portfolio?

IGUHEAL-25 provides pharma businesses with an additional Iguratimod 25 mg tablet option for their prescription pharmaceutical portfolio. It is suitable for businesses involved in pharma distribution, PCD franchise, pharmaceutical marketing, stockist operations and institutional supply.

For product availability, pricing, business enquiries, distribution opportunities and pharmaceutical partnership requirements, contact Farlex Pharmaceuticals.